Merck & Co., Inc. is 173.4x more valuable than Innoviva, Inc. by market capitalization ($293.16 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INVA | MRK |
|---|---|---|
| Market cap | $1.69 B | $293.16 B |
| US-listed rank | #2233 | #44 |
| Revenue (latest FY) | $411.33M | $65.01B |
| Net income (latest FY) | - | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 1,653 | 996 |
Merck & Co., Inc. is 173.4x more valuable than Innoviva, Inc. by market capitalization ($293.16 B vs $1.69 B).
In their latest fiscal years, Innoviva, Inc. reported $411.33M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Innoviva, Inc. and Merck & Co., Inc., or browse the full rankings.